Goldman Sachs’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$78.9K Sell
32,610
-151,197
-82% -$412K ﹤0.01% 6238
2025
Q4
$801K Buy
183,807
+150,463
+451% +$813K ﹤0.01% 5284
2025
Q3
$140K Buy
33,344
+18,306
+122% +$65K ﹤0.01% 6019
2025
Q2
$43.2K Sell
15,038
-73,425
-83% -$194K ﹤0.01% 5929
2025
Q1
$239K Buy
+88,463
New +$332K ﹤0.01% 5563
2024
Q3
Sell
-180,245
Closed -$351K 5928
2024
Q2
$351K Buy
180,245
+167,059
+1,267% +$568K ﹤0.01% 5015
2024
Q1
$84.8K Buy
+13,186
New +$120K ﹤0.01% 5269
2023
Q4
Sell
-25,383
Closed -$622K 5705
2023
Q3
$622K Buy
+25,383
New +$643K ﹤0.01% 4545
2023
Q2
Sell
-8,647
Closed -$240K 5870
2023
Q1
$240K Buy
+8,647
New +$140K ﹤0.01% 5221

Other funds holding GNLX

Goldman Sachs's GNLX Position: Q1 2026 in Review

Goldman Sachs reduced its Genelux (GNLX) stake by 82% in Q1 2026, selling an estimated $412K and leaving 32,610 shares worth $78.9K. The position accounts for ﹤0.01% of the portfolio, ranked #6238.

Goldman Sachs first reported a position in GNLX in Q1 2023 and has held it in 9 quarters since. The position peaked at $801K in Q4 2025. 71 funds tracked by Wall St. Rank hold GNLX as of Q1 2026.

  • Goldman Sachs held 32,610 shares of Genelux worth $78.9K as of Q1 2026.
  • Goldman Sachs sold 151,197 Genelux shares in Q1 2026, an estimated $412K.
  • Genelux made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #6238 holding.
  • Goldman Sachs first reported a position in Genelux in Q1 2023 and has held it in 9 quarters since.
  • Goldman Sachs's Genelux position peaked at $801K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Genelux as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.